About us
Services & Solutions
Chemistry Drug Metabolism and Pharmacokinetics (DMPK) Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Parallel Synthesis Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Fragment Based Drug Discovery (FBDD) Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry
Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
×

news

Company News Events Insights Webinars Virtual Tours

Using the Dr. Jekyll of Chemical Compounds to Advance Drug Synthesis

In 2018, Pfizer and BioDuro replaced sulfuryl fluoride gas with AISF, a solid for safer chemical handling in labs worldwide, advancing synthesis safety.
March 22, 2018

Production of Recombinant Proteins at BioDuro

BioDuro excels in recombinant protein production for biochemical and structural biology studies. Services include gene cloning, expression, purification,
March 20, 2018

BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent

Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent | Announcing the creation of AISF ([4-(Acetylamino)phenyl]- ...
March 19, 2018

BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities

BioDuro acquires Molecular Response to enhance translational oncology capabilities, providing access to a biobank of 100,000+ tumor specimens for drug discovery
March 05, 2018

BioDuro Announces Cooperation Agreement with Porton Pharma Solutions

BioDuro teams up with Porton Pharma Solutions to streamline global API and drug product development, aiming for accelerated timelines and efficient supply chains.
January 30, 2018
Total 88 12...101112131415161718
BIOSECURE Act Concerns?
We're a US-owned CRDMO partner offering speed, quality and cost savings, but without any geopolitical risks.
View more
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all